Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |